Musculoskeletal and CNS coccidiomycosis in an individual with multiple sclerosis on fingolimod - A case report

被引：0
|
作者：
Denton, Jacob [1 ]
Ozgur, Hasan [2 ]
Sazegar, Pantea [1 ]
Galgiani, John [3 ]
Riaz, Talha [4 ]
机构：
[1] Univ Arizona, Coll Med, Tucson, AZ USA
[2] Univ Arizona, Diagnost Radiol, Coll Med, Tucson, AZ USA
[3] Univ Arizona, Coll Med, Valley Fever Ctr Excellence, Tucson, AZ USA
[4] Banner Univ, Dept Internal Med, Div Infect Dis, Med Ctr, Tucson, AZ USA
来源：
IDCASES | 2024年 / 37卷
关键词：
Fingolimod; Multiple sclerosis; Coccidioides; CNS fungal infections;
D O I：
10.1016/j.idcr.2024.e02021
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We report the case of a 56-year-old female with a past medical history of multiple sclerosis on disease-modifying therapy of fingolimod who presented with disseminated Coccidioides infection, initially of the ankles bilaterally before progressing to the central nervous system. CNS coccidiomycosis has thus far not been associated with any pharmacological therapy for multiple sclerosis. Clinicians should have a high degree of suspicion for Coccidioides infection in immunosuppressed patients living in endemic areas.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Initiating oral fingolimod treatment in patients with multiple sclerosis
    Singer, Barry A.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2013, 6 (04) : 269 - 275
  • [42] Oral fingolimod for relapsing-remitting multiple sclerosis
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1777 - 1781
  • [43] Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients
    Ferraro, Diana
    De Biasi, Sara
    Simone, Anna Maria
    Orlandi, Riccardo
    Nasi, Milena
    Vitetta, Francesca
    Pinti, Marcello
    Fogliani, Marco
    Meletti, Stefano
    Cossarizza, Andrea
    Sola, Patrizia
    CELLS, 2021, 10 (12)
  • [44] Fingolimod - the First Approved Oral Medication in Multiple Sclerosis
    Dimova, R.
    Chervenkov, V.
    NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, 2011, 7 (02): : 137 - 143
  • [45] Hypothyroidism in multiple sclerosis patient during fingolimod treatment
    Flores, J.
    Rito, F.
    Torres, G.
    Jung, H.
    Trevino-Frenk, I.
    Corona, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 348 (1-2) : 272 - 273
  • [46] Fingolimod effects on left ventricular function in multiple sclerosis
    Racca, Vittorio
    Di Rienzo, Marco
    Cavarretta, Rosella
    Toccafondi, Anastasia
    Vaini, Emanuele
    Ferratini, Maurizio
    Rovaris, Marco
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (02) : 201 - 211
  • [47] Tumefactive multiple sclerosis in association with fingolimod initiation and discontinuation
    Croteau, David
    Tobenkin, Anne
    Brinker, Allen
    Kortepeter, Cindy M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (06) : 903 - 912
  • [48] Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome
    Signoriello, E.
    Sagliocchi, A.
    Fratta, M.
    Lus, G.
    ACTA NEUROLOGICA SCANDINAVICA, 2015, 131 (02): : 140 - 143
  • [49] Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis
    Volpi, Claudia
    Orabona, Ciriana
    Macchiarulo, Antonio
    Bianchi, Roberta
    Puccetti, Paolo
    Grohmann, Ursula
    EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (11) : 1199 - 1212
  • [50] Targeting synaptic pathology in multiple sclerosis: fingolimod to the rescue?
    Gillingwater, Thomas H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (04) : 858 - 860
12345